{{Drugbox
| verifiedrevid = 443772283
| IUPAC_name = (6''R'',7''R'')-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-7-([2-(trifluoromethylsulfanyl)acetyl]amino)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
| image = Cefazaflur.png
<!--Clinical data-->
| tradename =
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =
| routes_of_administration =
<!--Pharmacokinetic data-->
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =
<!--Identifiers-->
| CAS_number = 52123-49-6
| ATC_prefix = none
| ATC_suffix =
| ATC_supplemental =
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =
| ChEMBL = 2104456
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 97I0692RNT
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D03422
| PubChem = 40240
| ChemSpiderID = 36777
| smiles = O=C2N1/C(=C(\CS[C@@H]1[C@@H]2NC(=O)CSC(F)(F)F)CSc3nnnn3C)C(=O)O
| StdInChI = 1S/C13H13F3N6O4S3/c1-21-12(18-19-20-21)28-3-5-2-27-10-7(9(24)22(10)8(5)11(25)26)17-6(23)4-29-13(14,15)16/h7,10H,2-4H2,1H3,(H,17,23)(H,25,26)/t7-,10-/m1/s1
| StdInChIKey = HGXLJRWXCXSEJO-GMSGAONNSA-N
<!--Chemical data-->
| chemical_formula =
| C=13 | H=13 | F=3 | N=6 | O=4 | S=3
| molecular_weight = 470.470 g/mol
}}

'''Cefazaflur''' ([[International Nonproprietary Name|INN]]) is a first-generation [[cephalosporin]] antibiotic.
== Synthesis ==
Cefazaflur stands out among this group of analogues because it lacks an arylamide C-7 side chain (see [[cephacetrile]] for another example).
[[File:Cefazaflur synthesis.svg|thumb|center|700px|Cefazaflur synthesis:<ref>{{cite journal|doi=10.1021/jm00211a006|pmid=319233|title=Semisynthetic cephalosporins. Synthesis and structure-activity relations of analogs with 7-acyl groups derived from 2-(cyanomethylthio)acetic acid or 2-[(2,2,2-trifluoroethyl)thio]acetic acid and their sulfoxides and sulfones|journal=Journal of Medicinal Chemistry|volume=20|issue=1|pages=30â€“5|year=1977|last1=Demarinis|first1=R. M.|last2=Boehm|first2=J. C.|last3=Dunn|first3=G. L.|last4=Hoover|first4=J. R. E.|last5=Uri|first5=J. V.|last6=Guarini|first6=J. R.|last7=Phillips|first7=L.|last8=Actor|first8=P.|last9=Weisbach|first9=J. A.}}</ref>]]
Cefazaflur is synthesized by reaction of 3-(1-methyl-1<u>H</u>-tetrazol-5-ylthiomethylene)-7-amino-cephem-4-carboxylic acid ('''1''') with trifluoromethylthioacetyl chloride ('''2''').
== References ==
{{reflist|2}}
{{antibiotic-stub}}
{{CephalosporinAntiBiotics}}
[[Category:Cephalosporin antibiotics]]
[[Category:Enantiopure drugs]]
[[Category:Tetrazoles]]
[[Category:Organofluorides]]